Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04070105 · ClinicalTrials.gov registry record · NA
No Power Bionic Lower Extremity Prosthesis
A NA study of Amputation and Amputation, Traumatic, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT04070105: Completed NA study of Amputation and Amputation, Traumatic, sponsored by University of Michigan.
NCT04070105 is a NA study of Amputation and Amputation, Traumatic that has completed, run by University of Michigan. The registered enrollment target is 6 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04070105, a NA study of Amputation and Amputation, Traumatic, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Typically people need separate prosthetic feet for running and walking. To bridge the gap, this study will test the Compliant Adaptive Energy Storage and Return (CAESAR) foot. This foot can change from a walk mode to a run mode with the push of a button. The investigators will test and improve this foot design mechanically, and then test this design on individuals with lower limb amputation in a lab setting. The goal of this project is to develop a passive prosthetic foot that can serve two purposes in someone's daily life: walking and running, to allow them to be more active.
Primary Outcome
Participants will walk over sensors that measure the force under their foot. Peak ground reaction force in the anterior direction is measured in Newtons and then divided by the individual's body weight (BW). The resultant force is measured in Body-weights.
Conditions Studied
Interventions
- DEVICE Compliant Adaptive Energy Storage and Return Foot
- DEVICE AllPro
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04070105 record still lists
NCT04070105 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Compliant Adaptive Energy Storage and Return Foot is the first listed.
NCT04070105 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04070105 about?
NCT04070105 is a clinical study titled "No Power Bionic Lower Extremity Prosthesis". Typically people need separate prosthetic feet for running and walking. To bridge the gap, this study will test the Compliant Adaptive Energy Storage and Return (CAESAR) foot. This foot can change from a walk mode to a run mode with the push of a button. The investigators will test and improve this ...
What is the current status of trial NCT04070105?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-09-01. Estimated completion is 2022-12-31.
What conditions does trial NCT04070105 study?
This clinical trial studies the following conditions: Amputation, Amputation, Traumatic, Amputation; Traumatic, Leg, Lower.
What interventions are being tested in trial NCT04070105?
The interventions under investigation include: Compliant Adaptive Energy Storage and Return Foot (DEVICE), AllPro (DEVICE).
Who is sponsoring clinical trial NCT04070105?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04070105 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04070105's enrollment target sits among peer trials
6 55th of 65 higher than 8 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI